Search Within

Paul J Sabbatini

Formats
  1. Journal Article (157)
  2. Meeting Abstract (88)
  3. Book Section (15)
  4. Correspondence (1)
  5. Guidelines (1)
Groups
  1. Department of Medicine (262)
  2. GDMT, Medicine (262)
  3. Gynecologic Medicine Service (262)
  4. Gynecology Disease Management Team (262)
  5. Solid Tumor Oncology Division (262)
  6. Epidemiology and Biostatistics (82)

More Groups

People
  1. Carol Aghajanian (125)
  2. David Spriggs (81)
  3. Martee Hensley (81)
  4. Jason Konner (52)
  5. William Tew (52)
  6. Alexia Iasonos (44)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (7)
  4. 2022 (9)
  5. 2021 (4)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (72)
  2. Gynecologic Oncology (53)
  3. Clinical Cancer Research (17)
  4. International Journal of Gynecological Cancer (15)
  5. Journal of the National Comprehensive Cancer Network (11)
  6. Cancer (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (76)
  2. Elsevier Inc. (68)
  3. American Association for Cancer Research (23)
  4. Lippincott Williams & Wilkins (19)
  5. Harborside Press (11)
  6. Taylor & Francis Group (6)

More Publishers

Results (262)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MSK eConsent: Digitalizing the informed consent process to improve participant engagement and understanding
    Meeting Abstract

    Buckley, M. T.; Lengfellner, J. M.; Koch, M. J.; Search, B.; Hoidra, C.; Lin, M.; Kundu, S.; Cambria, R.; O'Shea, M.; Galle, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Impact of provider volume on front-line chemotherapy guideline compliance and overall survival in elderly patients with advanced ovarian cancer
    Journal Article

    Aviki, E. M.; Lavery, J. A.; Long Roche, K.; Cowan, R.; Dessources, K.; Basaran, D.; Green, A. K.; Aghajanian, C. A.; O'Cearbhaill, R.; Jewell, E. L.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy
    Journal Article

    Boland, J. L.; Zhou, Q.; Iasonos, A. E.; O'Cearbhaill, R. E.; Konner, J.; Callahan, M.; Friedman, C.; Aghajanian, C.; Sabbatini, P.; Zamarin, D.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
    Journal Article

    Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway
    Journal Article

    Rubinstein, M. M.; Hyman, D. M.; Caird, I.; Won, H.; Soldan, K.; Seier, K.; Iasonos, A.; Tew, W. P.; O’Cearbhaill, R. E.; Grisham, R. N.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Thirty day resource utilization after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J.; Sauter, C. S.; Duck, E.; Halton, E.; Batlevi, C. W.; Palomba, M. L.; Younes, A.; Geyer, M. B.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384) + OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study
    Journal Article

    O'Cearbhaill, R. E.; Deng, W.; Chen, L. M.; Lucci, J. A. 3rd; Behbakht, K.; Spirtos, N. M.; Muller, C. Y.; Benigno, B. B.; Powell, M. A.; Berry, E.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • A phase 2 study of TPIV200/ huFR-1 (a multi-epitope folate receptor alpha vaccine) in combination with durvalumab in patients with platinum resistant ovarian cancer
    Meeting Abstract

    Zamarin, D.; Yeku, O.; O'Cearbhaill, R. E.; Cadoo, K. A.; Gallagher, J.; Kravetz, S.; McDonnell, A.; Troso-Sandoval, T.; Sabbatini, P.; Lichtman, S.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Secondary surgical cytoreduction for recurrent ovarian cancer
    Journal Article

    Coleman, R. L.; Spirtos, N. M.; Enserro, D.; Herzog, T. J.; Sabbatini, P.; Armstrong, D. K.; Kim, J. W.; Park, S. Y.; Kim, B. G.; Nam, J. H.; more...
    New England Journal of Medicine (2019)

    Fulltext@MSK | Save
  • Feasibility of an outpatient 12-step desensitization for patients with history of carboplatin hypersensitivity reactions (HSR) undergoing retreatment with carboplatin for recurrent ovarian or endometrial cancer
    Meeting Abstract

    LaVigne, K.; Eroglu, I.; Mainardi, T.; Sabbatini, P.; Sklarin, N.; O'Cearbhaill, R.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save